n/a: n/a

Zalicus Inc. (ZLCS: NASDAQ)

$1.35 0.32 | 31.07%
04/16/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 1.03
52 Week High 8.28
52 Week Low 0.88
Avg. Daily Vol. (Mil) 0.68
Beta (3 year) 2.05
Share Related Items
Mkt Cap (Mil) 26.89
Shares Out (Mil) 26.11
Float (Mil) 21.12
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 1.40
Current Ratio 1.40
LT Debt/ Equity 0.19
Total Debt / Equity 0.68
Valuation Ratios
Price Earnings n.a.
Price/Sales 1.83
Price/Book 1.90
Price/Cash Flow -0.90
Per Share Data
Earnings -1.68
Sales 0.56
Book Value 0.54
Cash Flow -1.09
Business Summary
Zalicus Inc. is a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases.
General Information
245 First Street
Third Floor
Cambridge, MA 02142
Industry : Drugs
Sector: Health Care
Employees: 27
CEO: Mark H.N. Corrigan
Short Interest
Current Month (Mil) 1.20
Previous Month (Mil) 1.22
Short Interest Ratio (Days) 2.90
Management Effectiveness
Return on Equity n.a.
Return on Assets -120.30
Return on Investments -228.40
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ZLCS

Latest ZLCS Headlines from TheStreet

More Financial News for ZLCS

Press Releases for ZLCS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter